Piper Jaffray Starts Theravance Biopharma (TBPH) at Overweight

November 3, 2016 7:18 AM EDT
Get Alerts TBPH Hot Sheet
Price: $30.84 +1.58%

Rating Summary:
    4 Buy, 0 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade TBPH Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Piper Jaffray initiated coverage on Theravance Biopharma (NASDAQ: TBPH) with an Overweight rating and a price target of $42.

For an analyst ratings summary and ratings history on Theravance Biopharma click here. For more ratings news on Theravance Biopharma click here.

Shares of Theravance Biopharma closed at $25.10 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Piper Jaffray

Add Your Comment